---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-037044"
form_type: "8-K"
ticker: "CCEL"
cik: "0000862692"
company_name: "CRYO CELL INTERNATIONAL INC"
filed_at: "2021-07-19T23:59:59+00:00"
generated_at: "2026-06-30T04:40:13.028541+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cryo-Cell Q2 fiscal 2021 revenue down 8% to $7.21M; net income rises to $1.17M

## Summary
- Revenue $7.21M, down 8% from $7.87M; processing/storage fees $7.16M.
- Net income $1.17M ($0.15 basic EPS) vs $953K ($0.13) a year ago; net income up 23%.
- Cost of sales decreased 10% and SG&A decreased 12% year-over-year, offsetting revenue decline.
- Recorded $432K decrease in fair value of contingent consideration liability from Cord:Use earn-out; $240K amortization on Duke University license.

## SEC filing metadata
- accession: 0001564590-21-037044
- form_type: 8-K
- ticker: CCEL
- cik: 0000862692
- company_name: CRYO CELL INTERNATIONAL INC
- filed_at: 2021-07-19T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/862692/000156459021037044/0001564590-21-037044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/862692/000156459021037044/ccel-8k_20210715.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-037044
- JSON: https://secwatch.observer/filing/0001564590-21-037044.json
- Plain text: https://secwatch.observer/filing/0001564590-21-037044.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.